Clinical Trials on Relapse Leukemia in Switzerland

Total 167 results

Molecular Partners AG

Recruiting

Study of MP0533 in Patients With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome

Leukemia | Acute | Relapsed | Myeloid

Netherlands, France, Lithuania, Switzerland
Swiss Group for Clinical Cancer Research

Active, not recruiting

Ibrutinib lead-in Followed by Venetoclax Plus Ibrutinib in Patients With RR CLL

Leukemia | Chronic Lymphocytic Leukemia | Relapsed/Refractory Chronic Lymphocytic Leukemia

Switzerland
University Hospital Inselspital, Berne

Withdrawn

Epacadostat, Cladribine and Cytarabine (ECC) in AML (ECC)

AML | Relapse

Switzerland
University Hospital Inselspital, Berne

Recruiting

Drug-screening in AML at Relapse for Targeted Treatment (DARTT-1)

AML

Switzerland
Amgen

No longer available

Expanded Access Protocol - Blinatumomab in Pediatric & Adolescent Subjects With Relapsed/Refractory B-precursor ALL (RIALTO)

Relapsed/Refractory B-Precursor Acute Lymphoblastic Leukemia

United States, Italy, Germany, Austria, France, Switzerland, United Kingdom
Kantonsspital Aarau

Unknown

Laparoscopic Sacropexy With Robot-Assisted Surgical System (RobPex)

Vaginal Vault Prolapse

Switzerland
Kantonsspital Aarau

Unknown

Laparoscopic Sacropexy: Comparison of Mesh Attachment (MeshPlace)

Vaginal Vault Prolapse

Switzerland
National Cancer Institute (NCI)

Completed

Raltitrexed in Treating Children With Refractory Acute Leukemia

Recurrent Childhood Acute Lymphoblastic Leukemia | Recurrent Childhood Acute Myeloid Leukemia

Switzerland
Kite, A Gilead Company

Recruiting

Study of Brexucabtagene Autoleucel in Adults With Rare B-cell Malignancies (ZUMA-25)

Relapsed/Refractory Waldenstrom Macroglobulinemia | Relapsed/Refractory Richter Transformation | Relapsed/Refractory Burkitt Lymphoma | Relapsed/Refractory Hairy Cell Leukemia

United States, Spain, Germany, Italy, France, Netherlands, Switzerland, Austria
University Hospital Inselspital, Berne

Recruiting

Prophylactic Laparoscopic Suspension After McCall (LAPCALL)

Prolapse Pelvic

Switzerland
Nicolas C. Buchs

Unknown

Value of Robotic Rectopexy for the Treatment of Complex Pelvic Floor Dysfunction

Pelvic Organ Prolapse | Rectal Prolapse

Switzerland
David Scheiner
University of Zurich; ETH Zurich (Switzerland)

Unknown

Pelvic Floor Study: Biomechanical Properties of the Female Pelvic Floor

Pelvic Organ Prolapse

Switzerland
Kantonsspital Aarau

Completed

Laparoscopic Sacrocolpopexy: Long Term Follow-up

Vaginal Vault Prolapse

Switzerland
Kantonsspital Aarau

Recruiting

Laparoscopic Supracervical Hysterectomy and Sacropexy Versus Hysteropexy Study (HysPex)

Uterus Prolapse

Switzerland
Novartis Pharmaceuticals

Completed

Real-world Effectiveness of Asciminib and Treatment Patterns in Patients With Chronic Myeloid Leukemia With T315I Mutation - a Chart Review Study of Patients Treated in the Asciminib Managed Access Program (MAP)

Chronic Myeloid Leukemia With T315I Mutation

Switzerland
University of Zurich

Completed

Determination of Blood Tumor Cells

Leukemia, Lymphocytic, Chronic, B-Cell | Abnormalities Cell Epithelial

Switzerland
University of Birmingham
Assistance Publique - Hôpitaux de Paris; Pfizer; Cancer Research UK; National Cancer...

Recruiting

International Randomised Phase III Clinical Trial in Children With Acute Myeloid Leukaemia (Myechild01)

Acute Myeloid Leukaemia

France, Switzerland, United Kingdom, New Zealand, Australia, Ireland
University Hospital, Basel, Switzerland

Recruiting

Quality of Life After Conservative and Surgical Treatment of Pelvic Organ Prolapse (LOLIPOP)

Quality of Life | Pelvic Organ Prolapse | Incontinence

Switzerland
Swiss Group for Clinical Cancer Research

Completed

Daily or Weekly Cladribine in Treating Patients With Hairy Cell Leukemia

Leukemia

Switzerland
Pfizer

Recruiting

A Study to Learn More About the Study Medicine Called Inotuzumab Ozogamicin (InO) in Children (1 to <18 Years) With First Relapse ALL

ACUTE LYMPHOBLASTIC LEUKEMIA

Italy, Spain, Belgium, Germany, Hungary, Switzerland, Norway, Austria, France, Czechia, Finland, Netherlands, Sweden, Israel, Poland, Denmark, Greece, Slovakia
Swiss Group for Clinical Cancer Research

Completed

Rituximab in Treating Patients With Refractory or Recurrent Hairy Cell Leukemia Following Cladribine Therapy

Leukemia

Switzerland
Amgen

Completed

Phase 3 Trial of Blinatumomab vs Standard Chemotherapy in Pediatric Subjects With HIgh-Risk (HR) First Relapse B-precursor Acute Lymphoblastic Leukemia (ALL)

Leukemia, Acute Lymphoblastic

Italy, United Kingdom, Belgium, Mexico, Germany, Russian Federation, Turkey, Spain, Australia, Poland, Austria, Czechia, France, Portugal, Israel, Denmark, Brazil, Romania, Sweden, Switzerland, Norway, Netherlands, Argentina, Greece
Swiss Pediatric Oncology Group
ALL SCTped Forum

Recruiting

ALL SCTped FORUM - Pharmacogenomic Study (add-on Study)

Acute Lymphoblastic Leukemia

Switzerland
Cantonal Hosptal, Baselland

Unknown

Feasibility, Safety and Outcome of Transrectal Hybrid-NOTES Anterior Resection

Colon Adenoma | Sigmoid Diverticulosis | Sigmoid Diverticulitis | Rectal Prolapse

Switzerland
University Hospital, Basel, Switzerland
University Hospital, Geneva; University Hospital, Zürich

Completed

Cyclophosphamide and Busulfan as Conditioning Regimen Before Allogeneic HSCT

Myeloid Leukemia | Precursor Myeloid Neoplasms | Lymphoid Neoplasms

Switzerland
University Hospital, Basel, Switzerland

Recruiting

Expanded Natural Killer Cells Following Haploidentical HSCT for AML/MDS

Acute Myeloid Leukemia | Myelodysplastic Syndromes

Switzerland
Swiss Group for Clinical Cancer Research

Completed

Paclitaxel in Treating Patients With Refractory or Recurrent Acute Leukemia or Chronic Myelogenous Leukemia

Leukemia

Switzerland
Dr. med. Tanja Hülder

Completed

ProViS (Prolift+M and Vita Sexualis) Study (ProViS)

Pelvic Organ Prolapse

Germany, Switzerland
NeoChord

Recruiting

Multicenter Post-Market Observational Registry of the NeoChord Artificial Chordae Delivery System (AcChord)

Heart Valve Diseases | Mitral Regurgitation | Mitral Valve Insufficiency | Mitral Valve Prolapse | Mitral Valve Disease

Germany, Greece, Switzerland
Fred Hutchinson Cancer Center
National Cancer Institute (NCI)

Completed

Early Discharge and Outpatient Care After Chemotherapy in Patients With Myelodysplastic Syndrome or Acute Myeloid Leukemia

Myelodysplastic Syndromes | Leukemia

United States, Switzerland
University Hospital, Basel, Switzerland

Completed

NK DLI in Patients After Human Leukocyte Antigen (HLA)-Haploidentical Hematopoietic Stem Cell Transplantation (HSCT)

Lymphoma | Myelodysplastic Syndromes | Leukemia, Myeloid, Acute | Precursor Cell Lymphoblastic Leukemia-Lymphoma | Neuroblastoma | Rhabdomyosarcoma

Switzerland, Germany
Swiss Group for Clinical Cancer Research

Completed

Cladribine and Rituximab as Remission Induction Therapy Followed By Rituximab and Stem Cell Mobilization in Treating Patients With CLL

Leukemia

Switzerland
Glycostem Therapeutics BV

Recruiting

A Trial to Evaluate the Safety and Efficacy of oNKord® in Subjects With Acute Myeloid Leukemia

Acute Myeloid Leukemia

Belgium, Netherlands, Switzerland, France, Germany
European Society for Blood and Marrow Transplantation
Bristol-Myers Squibb

Terminated

Efficacy and Safety Study of Dasatinib in Patients With Chronic Myeloid Leukemia (Dasatinib)

Chronic Myeloid Leukemia

Switzerland, United Kingdom, France, Germany
St. Anna Kinderkrebsforschung
Assistance Publique - Hôpitaux de Paris; Australian & New Zealand Children's... and other collaborators

Recruiting

Allogeneic Stem Cell Transplantation for Children and Adolescents With Acute Lymphoblastic Leukaemia

Acute Lymphoblastic Leukaemia

Italy, Israel, Spain, Argentina, Australia, Austria, Belarus, Belgium, Canada, Chile, Croatia, Czechia, Denmark, Finland, Greece, Malaysia, Mexico, Netherlands, Norway, Poland, Romania, Saudi Arabia, Slovakia, Sweden, Switzerland, Turkey, F... and more
Swiss Group for Clinical Cancer Research

Completed

Azacitidine in Treating Patients With Newly Diagnosed Previously Untreated or Secondary Acute Myeloid Leukemia Who Are Unsuitable For Intensive Chemotherapy

Leukemia

Switzerland
Oncology Institute of Southern Switzerland

Active, not recruiting

Identification of Biomarkers That Are Predictive of Early Ibrutinib Treatment Failure in High Risk TP53 Mutated Chronic Lymphocytic Leukemia

Chronic Lymphocytic Leukemia

Italy, Switzerland
ImmunoGen, Inc.

Completed

IMGN529 in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma and Chronic Lymphocytic Leukemia

Lymphoma, Non-Hodgkin | Chronic Lymphocytic Leukemia

United States, Switzerland
OncoVerity, Inc.
Janssen Research & Development, LLC; argenx

Completed

A Study of ARGX-110 in Combination With Azacytidine in Participants With Newly Diagnosed Acute Myeloid Leukemia (AML) or High Risk Myelodysplatic Syndrome (MDS)

Myelodysplastic Syndromes | Leukemia, Myeloid, Acute

Switzerland, France
University of Zurich

Completed

Optimized Radiological Diagnosis of Hepatic Candidiasis During the Treatment of Acute Leukemias

Leukemia | Infection

Switzerland
University of Zurich
University Hospital, Zürich; Universitätsklinikum Hamburg-Eppendorf

Completed

Telephone-administered Relapse Prevention for Depression (NaTel)

Depressive Disorder

Germany, Switzerland
Bochud Pierre-Yves
Swiss National Science Foundation

Recruiting

PTX3-targeted Antifungal Prophylaxis (PTX3AML)

Acute Myeloid Leukemia | Candidiasis | Fungal Infection | Aspergillosis | Genetic Predisposition

Belgium, Switzerland, France
Hannover Medical School
CytoSorbents, Inc

Recruiting

Extracorporeal Cytokine Adsorption as Additive Treatment of CAR-T Associated Cytokine Release Syndrome (CRS) (CYTORELEASE)

Cytokine Release Syndrome | CAR-T

Germany, Switzerland
AbbVie

Completed

A Study to Assess Change in Disease State in Adult Participants With Acute Myeloid Leukemia (AML) Ineligible for Intensive Chemotherapy in Switzerland and Austria Receiving Oral Venetoclax Tablets (VALOR)

Acute Myeloid Leukemia

Austria, Switzerland
OncoVerity, Inc.
Janssen Research & Development, LLC; argenx

Active, not recruiting

Cusatuzumab in Combination With Background Therapy for the Treatment of Participants With Acute Myeloid Leukemia (ELEVATE)

Leukemia, Myeloid, Acute

Canada, United States, Poland, Switzerland, Germany
European Organisation for Research and Treatment...

Completed

Idarubicin, Cytarabine, and Gemtuzumab Ozogamicin in Treating Patients With Previously Untreated High-Risk Myelodysplastic Syndrome or Acute Myeloid Leukemia Secondary to Myelodysplastic Syndrome

Myelodysplastic Syndromes | Leukemia

Belgium, Switzerland, Netherlands, Germany
Insel Gruppe AG, University Hospital Bern

Not yet recruiting

PRONTO Trial (PRophylactic Versus ON-demand Use of TOcilizumab) (PRONTO)

Lymphoma | Leukemia | Myeloma

Switzerland
Celgene
Juno

Withdrawn

A Study to Determine Safety, Feasibility and Efficacy of JCAR015 in Adult Subjects With B-Cell Acute Lymphoblastic Leukemia (ORBIT)

Precursor Cell Lymphoblastic Leukemia-Lymphoma

Belgium, France, Spain, Italy, Germany, Switzerland, United Kingdom
Charite University, Berlin, Germany
European Organisation for Research and Treatment of Cancer - EORTC; Centre... and other collaborators

Completed

International Study for Treatment of Standard Risk Childhood Relapsed ALL 2010

Acute Lymphoblastic Leukemia (ALL)

United Kingdom, Norway, Germany, Italy, France, Belgium, Denmark, Australia, Austria, Czechia, Finland, Israel, Japan, Netherlands, Poland, Portugal, Switzerland
European Society for Blood and Marrow Transplantation
European Organisation for Research and Treatment of Cancer - EORTC; Swiss Group... and other collaborators

Terminated

HCT Versus CT in Elderly AML

Acute Myeloid Leukemia

Switzerland, Netherlands, Germany, France, Australia, Austria, Belgium

Clinical Trials on Relapse Leukemia in Switzerland

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Equatorial Guinea

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations